Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $150.1700 (0.88%) ($148.3300 - $150.1700) on Fri. Apr. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.06% (three month average) | RSI | 47 | Latest Price | $150.1700(0.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -1.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -2.53% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) IGOV(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.53% (StdDev 5.06%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $144.86(-3.54%) | Resistance Level | $152.12 | 5 Day Moving Average | $148.38(1.21%) | 10 Day Moving Average | $151.07(-0.6%) | 20 Day Moving Average | $152.12(-1.28%) | To recent high | -30.4% | To recent low | 15.2% | Market Cap | $2.413b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |